Rittenhouse Ventures

What Rittenhouse Ventures does

Rittenhouse Ventures is a Philadelphia-based, emerging-growth venture capital firm founded in 2006/2008 (originally as Emerald Stage2 Ventures) that invests in capital-efficient B2B SaaS, AI, and tech-enabled services companies. The firm concentrates on healthcare IT, fintech, and HR tech, with a Mid-Atlantic and underserved-US regional focus. Typical initial investments are ~$1M for minority equity stakes in companies generating $1M-$10M in revenue, with the firm often leading rounds and taking active board seats.

The firm operates across three funds: Fund I (2008, Emerald-backed), Fund II ($18M closed September 2016 with Ben Franklin Technology Partners and Innovate in PA), and Fund III ($75M+ AUM closed July 2025). Rittenhouse has executed 30+ investments and 20+ exits with cumulative portfolio exit values exceeding $3 billion, including the IPO of Tabula Rasa Healthcare on NASDAQ in 2016, and exits via acquisition to Litera (Prosperoware), Medecision (GSI Health), OSG Billing Services (Miria), and Gryphon Investors majority investment in HRSoft (March 2026). Active portfolio spans AI-powered AP automation (TranscendAP), MedTech commercial intelligence (S2N Health), clinical AI documentation (Pieces Technologies/Smarter Technologies), manufacturing QA (High QA), enterprise compensation management (HRSoft), UHNW trust CRM (WealthHub), patient engagement (GoMo Health, StationMD, Cecelia Health), precision pharmacy (GalenusCare), workforce microlearning (Bites), digital media monetization (Piano), behavioral health EHR (Core Solutions), lung intelligence (VIDA Diagnostics), antimicrobial technology (Noble Biomaterials), and K-12 professional learning (KickUp).

The firm monetizes via standard VC fund management economics: ~2% annual management fees on committed/deployed capital plus carried interest on exits. Distribution is sales-led through direct network sourcing, the Fund Advisory and Director Network of 200+ C-level executives, regional co-investor syndicates (Ben Franklin, Tech Council Ventures, Innovate in PA, Boston Millennia Partners, Robin Hood Ventures, Concord Health Partners), portfolio referrals, and selective event participation. Leadership comprises Founder & Managing Partner Saul Richter, GP Bruce Luehrs (Funds I & II), GP David Nevas (ex-Edison Partners, joined 2023), Partner Sushma Rajagopalan (ex-CEO ITC Infotech, joined 2025), CFO Steve Holstad, and Analyst Justin Hanley.

Name

Rittenhouse Ventures

Legal name

Rittenhouse Ventures LLC

Website

https://rittenhouseventures.com

Company type

Private

Founded year

2008

Operating status

Operating

Headcount range

1–10 employees

Short description

Rittenhouse Ventures is a Philadelphia-based early-stage venture capital firm that invests ~$1M initial checks in capital-efficient B2B SaaS, AI, and tech-enabled services companies in healthcare IT, fintech, and HR tech, primarily across the Mid-Atlantic region, managing $75M+ AUM across three funds.

Ownership category

akta.pro rank

Product category

Venture Capital

NAICS

Other Investment Pools and Funds (5259)

SIC

Investment Advice (6282)

akta.pro primary industry

Corporate Strategic Real Assets & Infrastructure Venture Investing (FSANAHAN)

akta.pro secondary industry

Real Estate / PropTech Growth Equity (FSANACAH)

Keywords

• Venture capital investing
• Early-stage technology investing
• Growth equity funding
• B2b software investment
• Healthcare tech venture capital

Headquarters

HQ city

Philadelphia

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales

Revenue model

1. Venture Capital Fund Management: Generates returns through equity investments in early-stage B2B software companies, with typical initial investments of ~$1M earning minority equity ownership stakes. Returns realized through exits including acquisitions, IPOs, and secondary sales.
2. Portfolio Company Value Creation: Provides strategic, operational and financial support to portfolio companies in exchange for equity ownership, generating returns upon exit events including acquisitions and public offerings.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Rittenhouse Ventures is a Philadelphia-based emerging-growth venture capital firm that invests in capital-efficient B2B SaaS, AI, and tech-enabled services companies. The firm provides right-sized equity investments (typically ~$1M for minority stakes) to companies with $1M-$10M in revenue, primarily in healthcare IT, financial technology, and human resources sectors, along with active board participation and operational support from investment to exit.

Product overview

Rittenhouse Ventures is a Philadelphia-based emerging-growth venture capital firm that invests in technology businesses, particularly B2B SaaS, AI, and tech-enabled services companies. The firm's portfolio consists of multiple independent portfolio companies across healthcare technology, financial technology, and enterprise software sectors. The portfolio includes AI-powered accounts payable automation (TranscendAP), MedTech commercial intelligence (S2N Health), clinical AI documentation (Pieces Technologies, Smarter Technologies), manufacturing quality management (High QA), compensation management (HRSoft), trust administration (WealthHub), patient engagement (GoMo Health, StationMD, Cecelia Health), precision pharmacy (GalenusCare), workforce microlearning (Bites), digital media monetization (Piano Software), behavioral health EHR (Core Solutions), lung intelligence (VIDA Diagnostics), antimicrobial technology (Noble Biomaterials), and education professional development (KickUp).

Differentiator

Problem solved

Functional benefit

Products and services

• Rittenhouse Fund I Founding institutional venture capital fund of Rittenhouse Ventures, deployed $20M in capital into early-stage software companies in healthcare IT, pharma IT, and fintech. Available to limited partner investors.
• Rittenhouse Fund II Second institutional venture capital fund, $18M of committed capital targeting capital-efficient, Mid-Atlantic software companies in healthcare, life sciences, finance, human resources, and general business services. Available to limited partner investors.
• Rittenhouse Fund III Third institutional venture capital fund with over $75M in assets under management, focused on capital-efficient B2B SaaS, AI, and tech-enabled services companies. Available to limited partner investors.

Quantifiable outcome

• Over $3 billion in total portfolio exit values
• +3 more outcomes

Named customers16 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration7 records

AI capability12 records

Feature2 records

Partnerships

Eight partnerships are on record, tiered core and minor.

• Smarter TechnologiescoreStrategic or Co-development Partner · 30 September 2025Acquired Pieces Technologies and launched SmarterNotes combining Pieces' note automation with SmarterDx's clinical AI for integrated documentation and revenue cycle intelligence.
• Benefits Administration PlatformminorChannel Partner/ Reseller/ Distributor · 19 February 2025New channel partnership with leading Benefits Administration company to white-label HRSoft's Total Rewards solution.
• MetroHealthcoreStrategic or Co-development Partner · 29 October 2024Premier academic medical center in Cleveland partnering with Pieces Technologies to deploy new conversational AI agent 'PiecesChat' for cancer patients.
• Amazon Web ServicescoreTechnology or Integration · 29 October 2024Pieces Technologies working with AWS using Amazon Bedrock, a fully managed service offering foundation models for generative AI capabilities.
• UKGcoreTechnology or IntegrationHRSoft platform integrates with leading HRIS systems including UKG and Workday for seamless compensation management.
• WorkdaycoreTechnology or IntegrationHRSoft platform integrates with Workday alongside UKG for compensation workflow automation.
• SalesforcecoreTechnology or IntegrationS2N Health's RepSignal platform natively integrates precision customer insights into Salesforce CRM; expanded partnership to include Agentforce AI platform.
• Pieces TechnologiescoreStrategic or Co-development PartnerSmarter Technologies acquired Pieces Technologies to launch SmarterNotes combining clinical documentation with revenue cycle intelligence.

Scale indicators7 records

Recent moves1 record

Expansion highlights5 records

Direct peers

• Edison Partners: Princeton/New Jersey-based growth equity firm focused on technology-enabled businesses, with similar check sizes and stage focus to Rittenhouse. The two firms are tightly linked: Rittenhouse co-founder Bruce Luehrs was previously a General Partner at Edison Venture Fund, and current GP David Nevas spent 20 years at Edison Partners before joining Rittenhouse in 2023.
• Osage Venture Partners: Philadelphia-area early-stage VC firm focused on B2B SaaS with comparable check sizes ($1-3M) and stage focus. Direct competitor for emerging-growth software deals in the Mid-Atlantic region, with overlapping portfolio themes in vertical SaaS and healthcare IT.
• NewSpring Capital: Philadelphia-area private equity/venture firm with similar Mid-Atlantic geographic focus and stage range. Direct peer in the lower middle-market technology investing space with overlapping healthcare IT and B2B SaaS themes.
• Boathouse Capital: Philadelphia-based growth equity firm focused on lower middle-market technology and business services companies. Comparable Mid-Atlantic geographic focus and stage range, with similar B2B software and healthcare IT exposure.
• LRVHealth: Healthcare-focused venture firm that invests exclusively in healthcare IT, digital health, and healthcare services companies. Direct peer for Rittenhouse's healthcare IT vertical investments with similar stage focus and comparable portfolio themes (clinical AI, value-based care).
• Robin Hood Ventures: Philadelphia-area angel/early-stage VC group that has co-invested with Rittenhouse in S2N Health. Direct competitor for early-stage deals in the Mid-Atlantic region with similar sector focus on B2B software.
• Tech Council Ventures: New Jersey-based venture firm that has co-led deals with Rittenhouse (most recently the $1.25M TranscendAP round via the NJ Innovation Evergreen Fund). Comparable stage focus and sector overlap in B2B SaaS and healthcare technology.
• Activate Venture Partners: Philadelphia-based early-stage VC focused on B2B SaaS, healthcare IT, and tech-enabled services. Direct peer in the Mid-Atlantic emerging-growth software market with comparable check sizes and stage focus.
• Excelerate Health Ventures: Healthcare-focused venture firm that has co-invested with Rittenhouse in S2N Health. Direct peer for Rittenhouse's healthcare vertical investments with comparable stage focus on emerging-growth B2B healthcare technology companies.
• Ben Franklin Technology Partners: Pennsylvania state-backed technology VC that has been both an LP in Rittenhouse's funds and a co-investor in multiple portfolio companies (WealthHub, others). Similar focus on early-stage healthcare IT, fintech, and HR tech in the Mid-Atlantic region.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/rittenhousevc
• Xx.com/rittenhousevc

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments40 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Rittenhouse Ventures